Industry News (Acquisitions)

Mycelex Troche Acquired in U.S.

Published in Cancer Weekly, July 14th, 1997

Alza Corp., Palo Alto, California, and Bayer Corp. announced that Alza has acquired Mycelex (clotrimazole) Troche in the United States.

Under the terms of the agreement, Bayer manufactures Mycelex Troche for Alza, and Alza makes payments to Bayer based on net sales of the product.

As a result of the agreement, Alza has exclusive marketing rights to Mycelex Troche in the United States. Since 1996, Alza has promoted Mycelex Troche under a promotion agreement with Bayer to AIDS healthcare providers, AIDS clinics, hospitals specializing in the treatment of AIDS patients, and to oncologists.

"The acquisition of Mycelex Troche...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-07-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry